Manulife Financial Corporation 13D/13G Filings for Travere Therapeutics, Inc. (TVTX)

Manulife Financial Corporation 13D and 13G filings for Travere Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-03
8:55 pm
Purchase
2020-12-31 13G Travere Therapeutics, Inc.
TVTX
Manulife Financial Corporation 2,157,055
11.000%
2,157,055increase
(New Position)
Filing